Baseline ECG and Prognosis After Transcatheter Aortic Valve Implantation: The Role of Interatrial Block.


Journal

Journal of the American Heart Association
ISSN: 2047-9980
Titre abrégé: J Am Heart Assoc
Pays: England
ID NLM: 101580524

Informations de publication

Date de publication:
17 11 2020
Historique:
pubmed: 4 11 2020
medline: 2 4 2021
entrez: 3 11 2020
Statut: ppublish

Résumé

Background The clinical significance of conduction disturbances after transcatheter aortic valve implantation has been described; however, little is known about the influence of baseline ECGs in the prognosis of these patients. Our aim was to study the influence of baseline ECG parameters, including interatrial block (IAB), in the prognosis of patients treated with transcatheter aortic valve implantation. Methods and Results The BIT (Baseline Interatrial Block and Transcatheter Aortic Valve Implantation) registry included 2527 patients with aortic stenosis treated with transcatheter aortic valve implantation. A centralized analysis of baseline ECGs was performed. Patients were divided into 4 groups: normal P wave duration (<120 ms); partial IAB (P wave duration ≥120 ms, positive in the inferior leads); advanced IAB (P wave duration ≥120 ms, biphasic [+/-] morphology in the inferior leads); and nonsinus rhythm (atrial fibrillation/flutter and paced rhythm). The mean age of patients was 82.6±9.8 years and 1397 (55.3%) were women. A total of 960 patients (38.0%) had a normal P wave, 582 (23.0%) had partial IAB, 300 (11.9%) had advanced IAB, and 685 (27.1%) presented with nonsinus rhythm. Mean follow-up duration was 465±171 days. Advanced IAB was the only independent predictor of all-cause mortality (hazard ratio [HR], 1.48; 95% CI, 1.10-1.98 [

Identifiants

pubmed: 33140688
doi: 10.1161/JAHA.120.017624
pmc: PMC7763710
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e017624

Investigateurs

Antonio Serra (A)
Dabit Arzamendi (D)
Xavier Millán (X)
Felipe Díez-delHoyo (F)
Lilian Grigorian (L)
Miriam Juárez (M)
M Eugenia Vázquez (ME)
Ricardo Sanz (R)
Enrique Gutiérrez (E)
Jaime Elízaga (J)
Francisco Fernández-Avilés (F)
Teresa Alvarado Casas (T)
Fernando Alfonso (F)
Agustín Albarrán González de Trevilla (A)
Julio García Tejada (J)
Iván Tomás Gómez Blázquez (IT)
Fernando Sarnago (F)
Carme Guerrero Morales (C)
Pablo Avanzas (P)
Yvan Persia (Y)
Cesar Moris (C)
Javier Cobiella (J)
Xoan Carlos Sanmartin Pena (XC)
Javier Lopez Pais (J)
Antonio Muñoz (A)
Erika Muñoz (E)
José María Hernández (JM)

Références

J Electrocardiol. 2019 Nov - Dec;57:100-103
pubmed: 31629098
Eur Heart J. 2015 Oct 7;36(38):2585-94
pubmed: 26224076
N Engl J Med. 2019 May 2;380(18):1695-1705
pubmed: 30883058
Int J Cardiol. 2014 Aug 1;175(2):248-52
pubmed: 24880480
JACC Cardiovasc Interv. 2016 Nov 14;9(21):2210-2216
pubmed: 27832846
Clin Res Cardiol. 2015 Jan;104(1):1-12
pubmed: 24990451
BMC Cardiovasc Disord. 2019 Feb 11;19(1):37
pubmed: 30744701
Rev Esp Cardiol (Engl Ed). 2020 Sep;73(9):758-762
pubmed: 32684442
J Cardiovasc Electrophysiol. 2020 Jul;31(7):1719-1725
pubmed: 32510679
JACC Cardiovasc Interv. 2015 Jan;8(1 Pt A):60-9
pubmed: 25616819
Heart Rhythm. 2016 Mar;13(3):645-51
pubmed: 26520207
Am J Cardiol. 2020 Feb 1;125(3):449-458
pubmed: 31780077
J Electrocardiol. 2015 Mar-Apr;48(2):135-40
pubmed: 25637273
Eur Heart J. 2016 Jul 14;37(27):2129-2200
pubmed: 27206819
J Electrocardiol. 2017 Sep - Oct;50(5):610-614
pubmed: 28515003
Clin Res Cardiol. 2018 Jan;107(1):60-69
pubmed: 28963581
J Interv Card Electrophysiol. 2013 Aug;37(2):147-54
pubmed: 23625090
Cardiology. 2019;142(2):109-115
pubmed: 31117073
J Geriatr Cardiol. 2018 Jan;15(1):105-112
pubmed: 29434632
Int J Cardiol. 2018 Nov 15;271:174-180
pubmed: 29801761
J Clin Orthop Trauma. 2020 Mar;11(Suppl 2):S201-S205
pubmed: 32189940
J Am Heart Assoc. 2020 Nov 17;9(22):e017624
pubmed: 33140688
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716
Eur Heart J. 1988 Oct;9(10):1112-8
pubmed: 3208776
Int J Cardiol. 2016 Nov 15;223:672-673
pubmed: 27568987
PLoS One. 2018 Oct 17;13(10):e0204503
pubmed: 30332419
J Electrocardiol. 2018 Jan - Feb;51(1):1-7
pubmed: 28969847
Am J Cardiol. 2019 Jun 15;123(12):2039-2043
pubmed: 30987829

Auteurs

Lourdes Vicent (L)

Department of Cardiology Hospital General Universitario Gregorio Marañón CIBERCV Madrid Spain.
Department of Cardiology Hospital General Universitario 12 de Octubre CIBERCV Madrid Spain.

Clara Fernández-Cordón (C)

Department of Cardiology Hospital General Universitario Gregorio Marañón CIBERCV Madrid Spain.

Luis Nombela-Franco (L)

Cardiovascular Institute Hospital Clinico San Carlos, IdISSC Madrid Spain.

Luis Alberto Escobar-Robledo (LA)

Department of Cardiology Hospital de la Santa Creu i Sant Pau. Fundación Investigación Cardiovascular. Programa-ICCC Cardiovascular Institut de Recerca del Hospital de la Santa Creu I Sant Pau IIB-Sant Pau Barcelona, Spain Barcelona Spain.

Ana Ayesta (A)

Department of Cardiology Hospital Universitario Central de Asturias Oviedo Asturias Spain.

Albert Ariza Solé (A)

Department of Cardiology Bellvitge University Hospital. L'Hospitalet de Llobregat Barcelona Spain.

Juan José Gómez-Doblas (JJ)

Department of Cardiology Hospital Universitario Virgen de la Victoria Málaga Spain.

Eva Bernal (E)

Department of Cardiology Hospital Universitari Germans Trias i Pujol Badalona Barcelona Spain.

Gabriela Tirado-Conte (G)

Cardiovascular Institute Hospital Clinico San Carlos, IdISSC Madrid Spain.

Javier Cobiella (J)

Cardiovascular Institute Hospital Clinico San Carlos, IdISSC Madrid Spain.

Hugo González-Saldivar (H)

Department of Cardiology Hospital General Universitario Gregorio Marañón CIBERCV Madrid Spain.

Diego López-Otero (D)

Department of Cardiology Hospital Cínico Universitario Santiago de Compostela Spain.

Pablo Díez-Villanueva (P)

Department of Cardiology Hospital Universitario de la Princesa Madrid Spain.

Fernando Sarnago (F)

Department of Cardiology Hospital General Universitario 12 de Octubre CIBERCV Madrid Spain.

Xavier Armario (X)

Department of Cardiology Hospital de la Santa Creu i Sant Pau. Fundación Investigación Cardiovascular. Programa-ICCC Cardiovascular Institut de Recerca del Hospital de la Santa Creu I Sant Pau IIB-Sant Pau Barcelona, Spain Barcelona Spain.

Antonio Bayés-de-Luna (A)

Department of Cardiology Hospital de la Santa Creu i Sant Pau. Fundación Investigación Cardiovascular. Programa-ICCC Cardiovascular Institut de Recerca del Hospital de la Santa Creu I Sant Pau IIB-Sant Pau Barcelona, Spain Barcelona Spain.

Manuel Martínez-Sellés (M)

Department of Cardiology Hospital General Universitario Gregorio Marañón CIBERCV Madrid Spain.
Universidad Europea Universidad Complutense Madrid Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH